Howard Temin

Howard Temin
Name	Howard Temin
Birth date	10 December 1934
Birth place	Philadelphia
Death date	9 February 1994
Death place	Madison, Wisconsin
Nationality	United States
Fields	Virology, Genetics, Molecular biology
Workplaces	University of Wisconsin–Madison, Cold Spring Harbor Laboratory, National Institutes of Health
Alma mater	Swarthmore College, University of Wisconsin–Madison
Doctoral advisor	Harold Henry Plough
Known for	Reverse transcriptase discovery, oncogene studies
Awards	Nobel Prize in Physiology or Medicine, Louisa Gross Horwitz Prize

Howard Temin

Howard Martin Temin was an American virologist and geneticist whose work transformed understanding of retrovirus biology, oncogenesis, and the flow of genetic information. His experiments with the Rous sarcoma virus challenged the prevailing central dogma and led to the discovery of reverse transcriptase, a finding that reshaped molecular biology, cancer research, and the biotechnology industry. Temin combined laboratory innovation, mentorship at the University of Wisconsin–Madison, and collaborations with researchers at institutions such as Cold Spring Harbor Laboratory and the National Institutes of Health.

Early life and education

Temin was born in Philadelphia to a family with roots in the Jewish community and received his secondary education in the United States. He attended Swarthmore College, where he studied biology and became interested in experimental research under faculty influenced by the American Association for the Advancement of Science milieu. He pursued graduate studies at the University of Wisconsin–Madison under advisors in cell biology and virology, performing doctoral work that interfaced with laboratories engaged in studies of bacteriophage and tumor viruses. During his graduate and postdoctoral periods he interacted with figures from institutions such as Rockefeller University, Cold Spring Harbor Laboratory, and the National Institutes of Health, absorbing contemporary techniques in tissue culture, electron microscopy, and nucleic acid biochemistry.

Research and career

Temin joined the faculty at the University of Wisconsin–Madison, developing a research program centered on the Rous sarcoma virus and viral carcinogenesis. He worked alongside colleagues in departments connected to the McArdle Laboratory for Cancer Research and fostered exchanges with visiting scientists from Addenbrooke's Hospital, Massachusetts Institute of Technology, and Cambridge University. Temin was notable for refining assays for viral transformation, using avian cells and fibroblast cultures, and for adapting biochemical fractionation methods that had been used in bacteriophage and poliovirus research. His laboratory produced influential papers that linked persistent infection by RNA-containing tumor viruses to stable genetic changes in host cells, positioning him at the center of debates involving researchers from Harvard University, Columbia University, and Stanford University over the mechanisms of oncogene activation.

Temin also spent sabbaticals and summers at major research hubs, interacting with investigators from the Pasteur Institute, Max Planck Society institutes, and the Karolinska Institute. His mentoring produced trainees who later joined faculties at institutions such as Yale University, Princeton University, and Johns Hopkins University. Administratively, Temin engaged with funding agencies including the National Cancer Institute and the National Institutes of Health to secure support for virus–host interaction studies.

Discovery of reverse transcriptase

Temin's central insight arose from experiments demonstrating that infection by Rous sarcoma virus caused permanent, heritable changes in cellular behavior. Challenging orthodox views articulated by proponents at Cambridge University and California Institute of Technology, he proposed that an RNA tumor virus must replicate via a DNA intermediate to integrate into host genomes. Temin's hypothesis paralleled theoretical work by researchers at Pasteur Institute and biochemical approaches used in bacteriophage studies.

In 1970, Temin, together with collaborators and independently alongside researchers at Cold Spring Harbor Laboratory and laboratories associated with Harvard University, reported enzymatic activity capable of synthesizing DNA from an RNA template. This enzyme, later named reverse transcriptase, provided direct biochemical proof that information could flow from RNA back to DNA, contradicting strict interpretations of the central dogma of molecular biology. The discovery was rapidly corroborated by groups at Rockefeller University and the National Institutes of Health, and it catalyzed advances in areas such as molecular cloning, cDNA synthesis, and diagnostic assays used by laboratories at Centers for Disease Control and Prevention and biotechnology firms emerging in Cambridge, Massachusetts and the San Francisco Bay Area.

Reverse transcriptase also illuminated mechanisms of viral oncogenesis and guided research into human pathogens studied at Mount Sinai Hospital, University College London, and Imperial College London. Methodologies stemming from Temin's discovery underpinned later work on viral integration, gene expression regulation, and retrotransposons investigated at institutions such as the Salk Institute and the Cold Spring Harbor Laboratory.

Awards and recognition

For the discovery of reverse transcriptase and its implications for oncology and molecular biology, Temin shared the Nobel Prize in Physiology or Medicine in 1975 with David Baltimore and Renato Dulbecco. He had previously received honors including the Louisa Gross Horwitz Prize and recognition from organizations such as the American Cancer Society and the National Academy of Sciences. Universities and research centers including the University of Wisconsin–Madison and Cold Spring Harbor Laboratory commemorated his contributions through symposia, named lectures, and endowed positions that connected his legacy to ongoing programs at Rockefeller University, Yale University, and other leading institutions.

Personal life and legacy

Temin maintained a lifelong commitment to mentoring and pedagogy, influencing generations of virologists and geneticists who later led laboratories at Princeton University, Johns Hopkins University, Stanford University, and Harvard Medical School. His career intersected with public health discussions involving the Centers for Disease Control and Prevention and policy considerations relevant to funding bodies like the National Institutes of Health and the National Science Foundation. After his death in Madison, Wisconsin, his impact continued through techniques and conceptual frameworks used in cancer centers at Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, and translational programs at University of California, San Francisco. Temin's work remains central to the histories of molecular biology, virology, and cancer research, and his scientific lineage is visible across laboratories and institutions worldwide.

Category:American virologists Category:Nobel laureates in Physiology or Medicine Category:University of Wisconsin–Madison faculty